110 related articles for article (PubMed ID: 29084365)
1. Views of dermatopathologists about clonality assays in the diagnosis of cutaneous T-cell and B-cell lymphoproliferative disorders.
Comfere N; Sundram U; Hurley MY; Swick B
J Cutan Pathol; 2018 Jan; 45(1):39-47. PubMed ID: 29084365
[TBL] [Abstract][Full Text] [Related]
2. Appropriate use criteria for ancillary diagnostic testing in dermatopathology: New recommendations for 11 tests and 220 clinical scenarios from the American Society of Dermatopathology Appropriate Use Criteria Committee.
; Fung MA; Vidal CI; Armbrecht EA; Andea AA; Cassarino DS; Comfere NI; Emanuel PO; Ferringer T; Hristov AC; Kim J; Lauer SR; Linos K; Missall TA; Motaparthi K; Novoa RA; Patel R; Shalin SC; Sundram U; ; Calame A; Bennett DD; Duncan LM; Elston DM; Hosler GA; Hurley YM; Lazar AJ; Lowe L; Messina J; Myles J; Plaza JA; Prieto VG; Reddy V; Schaffer A; Subtil A
J Cutan Pathol; 2022 Mar; 49(3):231-245. PubMed ID: 34536035
[TBL] [Abstract][Full Text] [Related]
3. Molecular immunoglobulin/T- cell receptor clonality analysis in cutaneous lymphoproliferations. Experience with the BIOMED-2 standardized polymerase chain reaction protocol.
Sandberg Y; Heule F; Lam K; Lugtenburg PJ; Wolvers-Tettero IL; van Dongen JJ; Langerak AW
Haematologica; 2003 Jun; 88(6):659-70. PubMed ID: 12801842
[TBL] [Abstract][Full Text] [Related]
4. Best practices in diagnostic immunohistochemistry: workup of cutaneous lymphoid lesions in the diagnosis of primary cutaneous lymphoma.
Dewar R; Andea AA; Guitart J; Arber DA; Weiss LM
Arch Pathol Lab Med; 2015 Mar; 139(3):338-50. PubMed ID: 25724031
[TBL] [Abstract][Full Text] [Related]
5. Molecular testing practices and perceptions among dermatopathologists.
Torre K; Jhorar P; Wu R; Pfeifer J; Elaba Z; Murphy M
J Cutan Pathol; 2018 Jun; 45(6):387-394. PubMed ID: 29436726
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of IGH/TCR PCR studies in lymphoproliferative disorders with inconclusive clonality by flow cytometry.
Ribera J; Zamora L; Juncà J; Rodríguez I; Marcé S; Cabezón M; Millá F
Cytometry B Clin Cytom; 2014 Jan; 86(1):25-31. PubMed ID: 23943305
[TBL] [Abstract][Full Text] [Related]
7. How concerns and experiences with medical malpractice affect dermatopathologists' perceptions of their diagnostic practices when interpreting cutaneous melanocytic lesions.
Carney PA; Frederick PD; Reisch LM; Knezevich S; Piepkorn MW; Barnhill RL; Elder DE; Geller BM; Titus L; Weinstock MA; Nelson HD; Elmore JG
J Am Acad Dermatol; 2016 Feb; 74(2):317-24; quiz 324.e1-8. PubMed ID: 26559597
[TBL] [Abstract][Full Text] [Related]
8. Clonality assessment of cutaneous B-cell lymphoid proliferations: a comparison of flow cytometry immunophenotyping, molecular studies, and immunohistochemistry/in situ hybridization and review of the literature.
Schafernak KT; Variakojis D; Goolsby CL; Tucker RM; Martínez-Escala ME; Smith FA; Dittman D; Chenn A; Guitart J
Am J Dermatopathol; 2014 Oct; 36(10):781-95. PubMed ID: 24335516
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of immunoglobulin κ light chain gene rearrangement analysis in B-cell lymphomas.
Kokovic I; Jezersek Novakovic B; Novakovic S
Int J Oncol; 2015 Mar; 46(3):953-62. PubMed ID: 25501347
[TBL] [Abstract][Full Text] [Related]
10. Evidence behind the use of molecular tests in melanocytic lesions and practice patterns of these tests by dermatopathologists.
Emanuel PO; Andea AA; Vidal CI; Missall TA; Novoa RA; Bohlke AK; Hughes SR; Hurley MY; Kim J
J Cutan Pathol; 2018 Nov; 45(11):839-846. PubMed ID: 30039879
[TBL] [Abstract][Full Text] [Related]
11. Differential diagnosis between cutaneous lymphoma and pseudolymphoma.
Cerroni L; Goteri G
Anal Quant Cytol Histol; 2003 Aug; 25(4):191-8. PubMed ID: 12961825
[TBL] [Abstract][Full Text] [Related]
12. Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936.
Evans PA; Pott Ch; Groenen PJ; Salles G; Davi F; Berger F; Garcia JF; van Krieken JH; Pals S; Kluin P; Schuuring E; Spaargaren M; Boone E; González D; Martinez B; Villuendas R; Gameiro P; Diss TC; Mills K; Morgan GJ; Carter GI; Milner BJ; Pearson D; Hummel M; Jung W; Ott M; Canioni D; Beldjord K; Bastard C; Delfau-Larue MH; van Dongen JJ; Molina TJ; Cabeçadas J
Leukemia; 2007 Feb; 21(2):207-14. PubMed ID: 17170731
[TBL] [Abstract][Full Text] [Related]
13. Managing Patients with Cutaneous B-Cell and T-Cell Lymphomas Other Than Mycosis Fungoides.
Kheterpal M; Mehta-Shah N; Virmani P; Myskowski PL; Moskowitz A; Horwitz SM
Curr Hematol Malig Rep; 2016 Jun; 11(3):224-33. PubMed ID: 27101016
[TBL] [Abstract][Full Text] [Related]
14. [Immunoglobulin heavy chain gene rearrangement study in difficult cases of B-cell lymphoproliferative disorder].
Wang Q; Li XQ; Zhu XZ; Zhu XL; Lu HF; Zhang TM; Zhou XY
Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):296-301. PubMed ID: 20654151
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Utility of a Clonality Test for Lymphoproliferative Diseases in Koreans Using the BIOMED-2 PCR Assay.
Kim Y; Choi YD; Choi C; Nam JH
Korean J Pathol; 2013 Oct; 47(5):458-65. PubMed ID: 24255634
[TBL] [Abstract][Full Text] [Related]
16. Molecular clonality assessment shows high performance to predict malignant B-cell non-Hodgkin's lymphoma using cytological smears.
Roepman P; Boots CM; Scheidel KC; Sprong T; de Bruin P; de Weerdt O; Groenen PJ; Kummer JA
J Clin Pathol; 2016 Dec; 69(12):1109-1115. PubMed ID: 27169754
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of B-cell clonality using the BIOMED-2 PCR method effectively distinguishes cutaneous B-cell lymphoma from benign lymphoid infiltrates.
Morales AV; Arber DA; Seo K; Kohler S; Kim YH; Sundram UN
Am J Dermatopathol; 2008 Oct; 30(5):425-30. PubMed ID: 18806482
[TBL] [Abstract][Full Text] [Related]
18. [Molecular diagnosis of malignant B-cell lymphoma: detection of clonality and a brief review of problems with our results].
Krsková L; Hilská I; Kopecká P; Soukup J; Kodet R
Cas Lek Cesk; 2004; 143(3):191-4. PubMed ID: 15134040
[TBL] [Abstract][Full Text] [Related]
19. Clonality testing of malignant lymphomas with the BIOMED-2 primers in a large cohort of 1969 primary and consultant biopsies.
Hartmann S; Helling A; Döring C; Renné C; Hansmann ML
Pathol Res Pract; 2013 Aug; 209(8):495-502. PubMed ID: 23827211
[TBL] [Abstract][Full Text] [Related]
20. The application of a PCR technique for the detection of immunoglobulin heavy chain gene rearrangements in fresh or paraffin-embedded skin tissue.
Hughes J; Weston S; Bennetts B; Prasad M; Angulo R; Jaworskit R; Jolles S; Kossard S; Fox S; Benson E
Pathology; 2001 May; 33(2):222-5. PubMed ID: 11358058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
